State Street Corp Ascendis Pharma A/S Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Ascendis Pharma A/S stock. As of the latest transaction made, State Street Corp holds 35,057 shares of ASND stock, worth $5.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,057

Previous 34,352 2.05%

Holding current value

$5.01 Million

Previous $5.19 Million 7.92%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$121.07 - $153.67 $85,354 - $108,337	705 Added 2.05%	35,057 $4.78 Million
Q1 2024 May 15, 2024	BUY	$123.45 - $159.4 $382,695 - $494,140	3,100 Added 9.92%	34,352 $5.19 Million
Q4 2023 Feb 14, 2024	BUY	$86.1 - $127.36 $45,202 - $66,864	525 Added 1.71%	31,252 $3.94 Million
Q3 2023 Nov 14, 2023	SELL	$86.5 - $103.97 $48,007 - $57,703	-555 Reduced 1.77%	30,727 $2.88 Million
Q2 2023 Aug 14, 2023	SELL	$69.96 - $97.84 $1.94 Million - $2.72 Million	-27,800 Reduced 47.05%	31,282 $2.79 Million
Q1 2023 May 15, 2023	SELL	$104.9 - $126.78 $2.83 Million - $3.42 Million	-26,967 Reduced 31.34%	59,082 $6.33 Million
Q4 2022 Feb 14, 2023	BUY	$99.42 - $131.97 $6.11 Million - $8.11 Million	61,429 Added 249.51%	86,049 $10.5 Million
Q3 2022 Nov 15, 2022	BUY	$84.03 - $110.23 $24,032 - $31,525	286 Added 1.18%	24,620 $2.54 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $1.23 Million - $1.85 Million	-15,720 Reduced 39.25%	24,334 $2.26 Million
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $1.6 Million - $2.13 Million	15,689 Added 64.39%	40,054 $4.7 Million
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $298,939 - $399,040	2,352 Added 10.68%	24,365 $3.28 Million
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $420,371 - $660,088	-3,731 Reduced 14.49%	22,013 $3.51 Million
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $222,199 - $265,444	1,827 Added 7.64%	25,744 $3.39 Million
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $290,938 - $403,685	2,329 Added 10.79%	23,917 $3.08 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $8,769 - $10,600	-58 Reduced 0.27%	21,588 $3.61 Million
Q3 2020 Nov 10, 2020	BUY	$134.29 - $154.32 $438,725 - $504,163	3,267 Added 17.78%	21,646 $3.34 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $377,844 - $531,682	3,408 Added 22.76%	18,379 $2.72 Million
Q1 2020 May 11, 2020	BUY	$97.01 - $145.11 $1.45 Million - $2.17 Million	14,971 New	14,971 $1.69 Million

Others Institutions Holding ASND

# of Institutions

223

Shares Held

56.5M

Call Options Held

142K

Put Options Held

259K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.97B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Ascendis Pharma A/S Transaction History